Coyote Bioscience, a leading molecular diagnosis company in China, announced today that it had completed Series B financing.  The round was led by Northern Light Ventures, with participation from SAIF Asia and Legend Star.
CEC Capital served as the exclusive financial advisor to Coyote in this transaction.